RENAISSANCE TECHNOLOGIES LLC

Position in TNGX — Tango Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in TNGX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$23,391,858

+$22,927,338 QoQ

Shares Held

748,300

+1253.2% QoQ

Ownership

0.444%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#46

of 247 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. TNGX ranks #32 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,391,858	748,300	+1253.2%	Shares	Sole	2026-08-13
2025-09-30	$464,520	55,300	-15.6%	Shares	Sole	2025-11-13
2025-06-30	$335,360	65,500	-62.5%	Shares	Sole	2025-08-13
2025-03-31	$239,065	174,500	+711.6%	Shares	Sole	2025-05-14
2024-12-31	$66,435	21,500	-67.2%	Shares	Sole	2025-02-13
2024-03-31	$520,864	65,600	-45.8%	Shares	Sole	2024-05-13
2023-12-31	$1,197,900	121,000	+216.8%	Shares	Sole	2024-02-13
2023-09-30	$430,132	38,200	-51.5%	Shares	Sole	2023-11-14
2023-06-30	$261,284	78,700	+29.2%	Shares	Sole	2023-08-11
2023-03-31	$240,555	60,900	+140.7%	Shares	Sole	2023-05-12
2022-12-31	$183,425	25,300	+125.9%	Shares	Sole	2023-02-13
2022-09-30	$40,544	11,200	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.